• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The toxicity of daily inhaled amphotericin B.

作者信息

Gryn J, Goldberg J, Johnson E, Siegel J, Inzerillo J

机构信息

Department of Medicine, Robert Wood Johnson School of Medicine/Cooper University Medical Center, Camden, New Jersey.

出版信息

Am J Clin Oncol. 1993 Feb;16(1):43-6. doi: 10.1097/00000421-199302000-00011.

DOI:10.1097/00000421-199302000-00011
PMID:8424403
Abstract

Inhaled amphotericin was administered to 29 patients with prolonged neutropenia and toxicity was analyzed. Treatment consisted of 30 mg of amphotericin B administered by nebulizer once daily via either a hand-held nebulizer or face mask. The mean duration of treatment was 16 days. Toxicity was minimal and patient had significant toxic reaction to the inhaled medication. This study documents that nebulized amphotericin B has less than 10% incidence of severe toxicity with 95% confidence level. Guidelines for future trials and use are suggested.

摘要

相似文献

1
The toxicity of daily inhaled amphotericin B.
Am J Clin Oncol. 1993 Feb;16(1):43-6. doi: 10.1097/00000421-199302000-00011.
2
A pilot study of prophylactic aerosolized amphotericin B in patients at risk for prolonged neutropenia.对有长期中性粒细胞减少风险患者预防性雾化两性霉素B的一项初步研究。
Leuk Lymphoma. 1992 Oct;8(3):229-33. doi: 10.3109/10428199209054909.
3
A review on the clinical use of inhaled amphotericin B.吸入性两性霉素B临床应用综述。
J Aerosol Med Pulm Drug Deliv. 2009 Sep;22(3):213-27. doi: 10.1089/jamp.2008.0715.
4
Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.5%葡萄糖溶液或20%脂肪乳剂中两性霉素B在中性粒细胞减少的肺炎或不明原因发热患者中的安全性和毒性：随机研究
BMJ. 1998 Aug 8;317(7155):379-84. doi: 10.1136/bmj.317.7155.379.
5
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.两性霉素B胶体分散体与两性霉素B用于发热性中性粒细胞减少症经验性治疗的随机双盲临床试验
Clin Infect Dis. 1998 Aug;27(2):296-302. doi: 10.1086/514672.
6
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.脂质体两性霉素B用于持续发热和中性粒细胞减少患者的经验性治疗。美国国立过敏和传染病研究所真菌病研究组。
N Engl J Med. 1999 Mar 11;340(10):764-71. doi: 10.1056/NEJM199903113401004.
7
Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.在接受脂质体两性霉素B预防治疗期间有深部或侵袭性真菌感染病史的患者的造血细胞移植。
Acta Haematol. 2005;113(2):104-8. doi: 10.1159/000083447.
8
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.静脉注射和口服伊曲康唑与静脉注射两性霉素B脱氧胆酸盐作为接受广谱抗菌治疗的癌症中性粒细胞减少患者持续发热的经验性抗真菌治疗。一项随机对照试验。
Ann Intern Med. 2001 Sep 18;135(6):412-22. doi: 10.7326/0003-4819-135-6-200109180-00010.
9
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia.
Ann Hematol. 1994 Jan;68(1):21-6. doi: 10.1007/BF01695915.
10
Inhaled amphotericin B as fungal prophylaxis in heart transplant recipients.吸入两性霉素B用于心脏移植受者的真菌预防
Conn Med. 2011 Nov-Dec;75(10):613-5.

引用本文的文献

1
Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?肺会是两性霉素B对抗真菌大军的门户吗？
Pharmaceutics. 2022 Dec 3;14(12):2707. doi: 10.3390/pharmaceutics14122707.
2
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections.用于治疗和预防支气管肺侵袭性霉菌感染的吸入性抗真菌药物
Pharmaceutics. 2022 Mar 14;14(3):641. doi: 10.3390/pharmaceutics14030641.
3
Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models.
两性霉素 B 去氧胆酸钠硫酸酯制剂经气管内滴注在大鼠模型中的生物分布和组织病理学研究。
Drug Deliv Transl Res. 2020 Feb;10(1):59-69. doi: 10.1007/s13346-019-00662-x.
4
Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.用于呼吸道感染的吸入式抗感染化疗：成就、挑战与未来之路。
Adv Drug Deliv Rev. 2015 May;85:65-82. doi: 10.1016/j.addr.2014.11.004. Epub 2014 Nov 12.
5
A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties.一种载有两性霉素 B 的磷脂-载脂蛋白 A-I 纳米颗粒，作为具有细胞膜保护特性的药物递送平台。
Int J Pharm. 2010 Oct 31;399(1-2):148-55. doi: 10.1016/j.ijpharm.2010.07.057. Epub 2010 Aug 7.
6
Aerosolized Delivery of Antifungal Agents.抗真菌药物的雾化给药
Curr Fungal Infect Rep. 2010 Jun;4(2):96-102. doi: 10.1007/s12281-010-0011-0. Epub 2010 Apr 13.
7
Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients.两性霉素B吸入预防血液病患者侵袭性肺曲霉病的耐受性和疗效
Eur J Clin Microbiol Infect Dis. 1997 May;16(5):364-8. doi: 10.1007/BF01726364.
8
Antifungal prophylaxis during neutropenia and immunodeficiency.中性粒细胞减少和免疫缺陷期间的抗真菌预防
Clin Microbiol Rev. 1997 Jul;10(3):477-504. doi: 10.1128/CMR.10.3.477.
9
Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.预防性雾化两性霉素B脂质复合物在大鼠肺曲霉病模型中的疗效
Antimicrob Agents Chemother. 1997 Feb;41(2):259-61. doi: 10.1128/AAC.41.2.259.
10
Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.雾化吸入两性霉素B预防中性粒细胞减少癌症患者侵袭性肺曲霉病
Ann Hematol. 1995 Dec;71(6):287-91. doi: 10.1007/BF01697981.